Lymphangiogenesis and cancer metastasis

被引：644

作者：

Stacker, SA

Achen, MG

Jussila, L

Baldwin, ME

Alitalo, K ^{[1
]}

机构：

[1] Univ Helsinki, Haartman Inst, Mol Canc Biol Lab, FIN-00014 Helsinki, Finland

[2] Univ Helsinki, Haartman Inst, Ludwig Inst Canc Res, FIN-00014 Helsinki, Finland

[3] Univ Helsinki, Biomedicum, Ludwig Inst Canc Res, FIN-00014 Helsinki, Finland

[4] Univ Helsinki, Biomedicum, Mol Canc Biol Lab, FIN-00014 Helsinki, Finland

来源：

NATURE REVIEWS CANCER | 2002年 / 2卷 / 08期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1038/nrc863

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Lymphatic vessels are important for the spread of solid tumours, but the mechanisms that underlie lymphatic spread and the role of lymphangiogenesis (the growth of lymphatics) in tumour metastasis has been less clear This article reviews recent experimental and clinico-pathological data indicating that growth factors that stimulate lymphangiogenesis in tumours are associated with an enhanced metastatic process.

引用

页码：573 / 583

页数：11

共 124 条

[1] Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3 [J].

Achen, MG ;

Roufail, S ;

Domagala, T ;

Catimel, B ;

Nice, EC ;

Geleick, DM ;

Murphy, R ;

Scott, AM ;

Caesar, C ;

Makinen, T ;

Alitalo, K ;

Stacker, SA .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (09) :2505-2515

[2] The angiogenic and lymphangiogenic factor vascular endothelial growth factor-D exhibits a paracrine mode of action in cancer [J].

Achen, MG ;

Williams, RA ;

Baldwin, ME ;

Lai, P ;

Roufail, S ;

Alitalo, K ;

Stacker, SA .

GROWTH FACTORS, 2002, 20 (02) :99-107

[3]

Achen MG, 2001, J PATHOL, V193, P147, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH757>3.0.CO

[4]

2-G

[5] Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) [J].

Achen, MG ;

Jeltsch, M ;

Kukk, E ;

Mäkinen, T ;

Vitali, A ;

Wilks, AF ;

Alitalo, K ;

Stacker, SA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :548-553

[6] Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues [J].

Akagi, K ;

Ikeda, Y ;

Miyazaki, M ;

Abe, T ;

Kinoshita, J ;

Maehara, Y ;

Sugimachi, K .

BRITISH JOURNAL OF CANCER, 2000, 83 (07) :887-891

[7] Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma [J].

Albertini, JJ ;

Cruse, CW ;

Rapaport, D ;

Wells, K ;

Ross, M ;

DeConti, R ;

Berman, CG ;

Jared, K ;

Messina, J ;

Lyman, G ;

Glass, F ;

Fenske, N ;

Reintgen, DS .

ANNALS OF SURGERY, 1996, 223 (02) :217-224

[8] Lymphatic mapping and sentinel node biopsy in the patient with breast cancer [J].

Albertini, JJ ;

Lyman, GH ;

Cox, C ;

Yeatman, T ;

Balducci, L ;

Ku, NN ;

Shivers, S ;

Berman, C ;

Wells, K ;

Rapaport, D ;

Shons, A ;

Horton, J ;

Greenberg, H ;

Nicosia, S ;

Clark, R ;

Cantor, A ;

Reintgen, DS .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (22) :1818-1822

[9]

ASELLI G, 1627, LACTEIBUS SIVE LACTI

[10] The specificity of receptor binding by vascular endothelial growth factor-D is different in mouse and man [J].

Baldwin, ME ;

Catimel, B ;

Nice, EC ;

Roufail, S ;

Hall, NE ;

Stenvers, KL ;

Karkkainen, MJ ;

Alitalo, K ;

Stacker, SA ;

Achen, MG .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (22) :19166-19171

← 1 2 3 4 5 6 7 8 9 10 →